Search Options Stock News and Analysis from Schaeffer's

Weak Drug Sales Undermine BIIB's Earnings Beat

https://www.schaeffersresearch.com/content/news/2021/04/22/weak-drug-sales-undermine-biibs-earnings-beat

4/22/2021 9:57 AM

The shares of Biogen Inc (NASDAQ:BIIB) were last seen down 3.9% at $259.23, even after the pharmaceutical concern posted first-quarter earnings of $5.34 per share, which topped analysts' estimates. T...

Options Traders Pile on Biogen Stock Following FDA Update

https://www.schaeffersresearch.com/content/news/2021/01/29/options-traders-pile-on-biogen-stock-following-fda-update

1/29/2021 10:24 AM

Biopharmaceutical concern Biogen Inc (NASDAQ:BIIB) is up 7.9% to trade at $291.00 this morning, after the Food and Drug Administration (FDA) extended the review period for Biogen's experimental Alzhe...

Sage Stock Slips Amid Biogen Deal Critique

https://www.schaeffersresearch.com/content/news/2020/12/01/sage-stock-slips-amid-biogen-deal-critique

12/1/2020 11:57 AM

The shares of Sage Therapeutics Inc (NASDAQ:SAGE) are down 1.8% at $72.78 at last check, after Raymond James downgraded the stock to "Market Perform" from "Outperform," following its recent $1.5 bill...

Morgan Stanley Double Upgrade Blows BIIB Out of the Water

https://www.schaeffersresearch.com/content/news/2020/07/27/morgan-stanley-double-upgrade-blows-biib-out-of-the-water

7/27/2020 10:36 AM

Pharmaceutical name Biogen Inc (NASDAQ:BIIB) is soaring today, up 4.2% to trade at $283.89, on a double upgrade from Morgan Stanley. The analyst lifted its rating to "overweight" from "underweight" a...

Biogen Stock Moves Higher After Q2 Earnings Beat

https://www.schaeffersresearch.com/content/news/2020/07/22/biogen-stock-moves-higher-after-q2-earnings-beat

7/22/2020 10:06 AM

The shares of Biogen Inc (NASDAQ: BIIB) are up 1.8% at $285.23 this morning, after the multinational biotechnology company reported second-quarter profits of $10.26 per share on 3.68 billion in revenu...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity

-notable-earning-reports